Safety, tolerability and pharmacokinetics of SMP-114 (a novel candidate DMARD) in healthy volunteers

Trial Profile

Safety, tolerability and pharmacokinetics of SMP-114 (a novel candidate DMARD) in healthy volunteers

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Sep 2009

At a glance

  • Drugs Rimacalib (Primary)
  • Indications Rheumatoid arthritis
  • Focus Pharmacokinetics
  • Acronyms ARREST
  • Most Recent Events

    • 20 Sep 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top